Foothold Labs
Foothold Labs commercializes the NanoRev platform that provides rapid, affordable diagnostic results at the point of need. It combines next-generation electrochemical sensors with machine learning to detect infectious disease biomarkers and other analytical targets. The technology originated from a license with the U.S. Naval Research Laboratory and is designed for point-of-care healthcare applications. Foothold partners with academic and government labs for pharmaceutical research, diagnostics, and toxic threat detection, with potential integrations into clinical workflows. The platform aims to scale accessible, quantitative results and enable fast decision-making in diverse settings.
Foothold Labs
Foothold Labs commercializes the NanoRev platform that provides rapid, affordable diagnostic results at the point of need. It combines next-generation electrochemical sensors with machine learning to detect infectious disease biomarkers and other analytical targets. The technology originated from a license with the U.S. Naval Research Laboratory and is designed for point-of-care healthcare applications. Foothold partners with academic and government labs for pharmaceutical research, diagnostics, and toxic threat detection, with potential integrations into clinical workflows. The platform aims to scale accessible, quantitative results and enable fast decision-making in diverse settings.